Phimosis and topical steroids: New clinical findings

Pediatric Surgery International

Volumn 23, Issue 4, 2007, Pages 331-335

  Zampieri, Nicola ^a,b   Corroppolo, Michele ^a   Zuin, Veronica ^a   Bianchi, Sanzio ^a   Camoglio, Francesco Saverio ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Policlinico G B Rossi   (Italy)

Author keywords

Non operative treatment; Phimosis; Topical steroids

Indexed keywords

BETAMETHASONE;

ADOLESCENT; ARTICLE; CHILD; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; EXPOSURE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PENIS GLANS; PHIMOSIS; PREPUCE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADOLESCENT; BETAMETHASONE; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; ELASTICITY; FOLLOW-UP STUDIES; FORESKIN; GLUCOCORTICOIDS; HUMANS; MALE; PHIMOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33947514700     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-007-1878-x     Document Type: Article

References (30)

1. Jorgensen ET, Svenson A (1993) The treatment of phimosis in boys with a potent topical steroid (clobetsol propinate 0.05%) cream. Acta Derm Venerol 3:673-676
2. Monsour MA, Rabinovitch HH, Dean GE (1999) Medical management of phimosis in children: our experience with topical steroids. J Urol 162:1162-1164
3. Atilla MK, Dundaroz R, Odabas O, Ozturk H et al (1997) A non surgical approach to the treatment of phimosis: local nonsteroidal anti-inflammatory ointment application. J Urol 158:196-197
4. Chu CC, Chen KC, Diau GY (1999) Topical steroid treatment of phimosis in boys. J Urol 162:861-863
5. Iken A, Ben Mouelli S, Fontaine E, Quenneville V et al (2002) Treatment of phimosis with locally applied 0.05% clobetasol propionate. Prospective study with 108 children. Prog Urol 12:1268-1271
6. Van Basten JP, De Vijlder AM, Mensink HJ (2003) The use of corticosteroid cream to treat phimosis. Ned Tijdschr Geneeskd 147:1544-1547
7. Elmore JM, Baker LA, Snodgrass WT (2002) Topical steroid therapy as an alternative to circumcision for phimosis in boys younger than 3 years. J Urol 168:1746-1747
8. Ashfield JE, Nickel KR, Siemens DR, MacNeily AE, Nickel JC (2003) Treatment of phimosis with topical steroids in 194 children. J Urol 169:1106-1108
9. Orsola A, Caffaratti J, Garat JM (2000) Conservative treatment of phimosis in children using a topical steroid. Urology 56:307-310
10. Webster TM, Leonard MP (2002) Topical steroid therapy for phimosis. Can J Urol 9:1492-1495
11. Kikiros CS, Beasley SW, Woodward AA (1993) The response of phimosis to local steroid application. Pediatr Surg Int 8:329-332
12. Gainder D (1949) The fate of the foreskin. BMJ 2:1433-1437
13. Rickwood AMK, Hemalatha V, Batcup G, Spitz L (1980) Phimosis in boys. Br J Urol 52:147-150
14. Kayaba H, Tamura H, Kitajima S, Fujiwara Y, Kato T, Kato T (1996) Analysis of shape and retractability of the prepuce in 603 japanese boys. J Urol 156:1813-1815
15. Zampieri N, Corroppolo M, Camoglio FS, Giacomello L, Ottolenghi A (2005) Phimosis: stretching methods with or without application of topical steroids? J Pediatr 147(5): 705-706
16. Miller JA, Munro DD (1980) Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs 19:119-134
17. Brazzini B, Pimpinelli N (2002) New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol 3:47-58
18. Rao LS, Long WS, Kaneko T, Blumenberg M (2003) Regulation of trascription factor activity by extracellular signals in epidermal keratinocytes. Acta Dermatoven 12:3-14
19. Radoja N, Nomine M, Jho SH, Blumenberg M, Tomic-canic M (2000) Novel mechanism of steroid action in skin through glucocorticoid receptor monomers. Mol Cell Biol 20:4328-4339
20. Austin RJH, Maschera B, Walker A, Fairbairn L, Meldrum E, Farrow SN, Uings IJ (2002) Mometasone fuorate is a less specific glucocorticoid than fluticonasone propionate. Eur Respir J 20:1386-1392
21. Croxtall JD, Paul-Clark M, Van Hall PTW (2003) Differential modulation of glucorticoid action by FK506 in A549 cells. Biochem J 376:285-290
22. Panarelli M, Holloway CD, Fraser R, Connell JMC, Ingram MC, Anderson NH, Kenyon CJ (1998) Glucorticoid receptor polymorphism, skin vasoconstriction and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab 83:1846-1852
23. Bonacci JV, Harris T, Wilson JW, Stewart AG (2003) Collagen-induced resistance to glucocorticoid anti-mitogenic actions: a potential explanation of smooth muscle hyperplasia in the asthmatic remodeled airway. Br J Pharmacol 138:1203-1206
24. Oikarien A, Salo T, Ala-Kokko L, Tryggvason K (1987) Dexamethasone modulates the metabolism of type IV collagen and fidronectin in human basement-membrane-forming fibrosarcoma (HT-1080) cells. J Biochem 245:235-241
25. Barnes PJ (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 94:557-572
26. Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Holtje HD, Schafer-Korting M (1999) Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm Res 16:1386-1391
27. Oikarinen A, Oikarinen H, Tan EM, Uitto J (1987) Modulation of collagen metabolism in cultured human skin fibroblasts by dexamethasone: correlation with glucocorticoid receptor density. Acta Derm Venereol 67:106-115
28. EFL (2005) Clinical potencies of glucocorticoids: what do we really measure? Curr Respir Med Rev 1:103-108
29. Bray PL, Du B, Mejia VM, Hao SC, Deutsch E, Fu C, Wilson RC, Hanauske-Abel H, McCaffrey TA (1999) Glucocorticoid resistance caused by reduced expression of the glucorticoid receptor in cells from human vascular lesions. Arterioscler Thromb Vasc Biol 19:1180-1189
30. Jefferson G, Lond MS, Victoria FRCS BC (1916) The peripenic muscle: some observations on the anatomy of phimosis. Surg Gynecol Obstet 23(2):177-181